PPHM—I'm less into conspiracy, and more into believing inept mgmt.
Me too—in general; this is one of the very rare cases where the nutty conspiracy theory may ring true.
Without the data screw-up, Bavituximab probably wouldn’t be in phase-3 now and management would have nothing to talk about except incessant preclinical data, single-arm ISTs, and musings on the hypothesized MoA. Think about it.
Moreover, how would CSM even come up with the legal defense that PPHM ordered them to switch the batches if there weren’t at least a germ of truth there?
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.